Search
Intellia Therapeutics Inc
NTLAAdd to Watchlist
10.680USD
-0.410-3.70%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.49BMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-31The current institutional shareholding score of Intellia Therapeutics Inc is 7.00, ranking 80 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 86.89%, representing a quarter-over-quarter decrease of 4.63%. The largest institutional shareholder is Catherine Wood, holding a total of 13.84M shares, representing 12.05% of shares outstanding, with 16.04% increase in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
D. E. Shaw & Co., L.P.
Two Sigma Investments, LP
Regeneron Pharmaceuticals Inc
Geode Capital Management, L.L.C.
1
2